Plain-English translation of NCT07225842 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This research study is testing whether personalizing the dose of —a blood-thinning medication—based on individual blood test results works better than using a one-size-fits-all approach. is already used as standard care to help prevent blood clots in heart patients, but this study wants to see if adjusting the dose to match each person's needs could improve outcomes.
Blood thinners work differently in different people, and doctors don't always know which dose is best for each patient. This study is trying to figure out if measuring how well the medication is working in your blood and then adjusting your dose accordingly could lead to better, safer treatment.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have blood tests done to measure how well the medication is working in your system. Based on those results, your medication dose may be adjusted up or down. You'll then have additional blood samples collected over the next few days (up to 3 more times) to see how your body responds to the new dose. All of this happens while you're already at the hospital waiting for your scheduled procedure, so it won't add extra visits or delay your care.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States
Phase
Post-approval monitoring
Sponsor
University of Florida
Enrollment target
~50 participants
Started
February 2026
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Luis Ortega-Paz, MD, PhD
University of Florida College of Medicine - Jacksonville
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.